Not sure tariffs are a significant issue for us, as we are produced inside the US. Its more likely that NEU's share price is being caught up in the broader FDA turmoil, as well as uncertainty surrounding potential policy shifts under Trump / RFK Jr, which may mean possible impacts to trial timelines, requirements and approval processes (speculation on my part). Its not just us, but as always with NEU, any perceived weakness appears to be aggressively exploited (for whatever reason).
Just my opinion of whats going on of course (DYOR). I am hanging tight for the time being and seeing if i can grab some funds to add to my small position.
NEU Price at posting:
$10.86 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)